Public-health experts say that if the therapy proves safe and effective in human trials, it could reduce long-term disability and healthcare costs linked to Chikungunya, while strengthening India’s preparedness for future outbreaks.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/zgnw8X4
via
ICMR steps in as Chikungunya cases rise across India
January 20, 2026
0
Tags
-min.png)